Heart Implants (Global Market)

Cardiac Implants (Russian Market)

Main article: Heart implants (Russian market)

2023: Biodegradable implant introduced to monitor heart function

On July 5, 2021, American researchers from Northwestern University and George Washington University announced the development of a new implantable device for monitoring heart activity. Read more here.

2018: Artificial heart valves sales reach $9.28 billion

In early June 2019, the analytical company MarketsandMarkets presented a research report, according to which the global market for devices used to replace affected heart valves will reach $15 billion by 2023, while back in 2018 it was $9.28 billion. The largest manufacturers of such implants are named Edwards Lifesciences and Medtronic.

To blame these companies, analysts distinguish several more major players: Abbott Laboratories (USA), Boston Scientific ( USA) and LivaNova (UK). Merging and entering into partnership agreements became the main strategy of these companies, and by 2019 such large firms as Micro Interventional Devices (USA), Braile Biomédica (Brazil) and CryoLife (USA) joined them.

The largest manufacturers of artificial heart valves are Edwards Lifesciences and Medtronic

Edwards Lifesciences has taken a leading position in the global market due to its diverse range of valve replacement products. The company is constantly expanding: for example, in December 2017, it acquired Harpoon Medical (USA) for $100 million, which supplemented the Edwards portfolio with a unique technology for implanting a mitral valve without cardiac arrest.

Medtronic took the second position in the artificial valve manufacturers market. The company offers a wide range of products for traditional and transcatheter implantation of heart valves. To maintain a leading market position and increase the customer base, the company focuses on developing new devices, entering into partnership agreements and expanding production. For example, the company has partnered with the World Stroke Organization (WSO, Switzerland). As part of this partnership, the two organizations inform the population about the problem of stroke and its consequences, as well as ensure the effective management of post-stroke patients.^[1]

Notes